558 related articles for article (PubMed ID: 11223544)
1. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells.
Sugimoto T; Kuroda H; Horii Y; Moritake H; Tanaka T; Hattori S
Jpn J Cancer Res; 2001 Feb; 92(2):152-60. PubMed ID: 11223544
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of TRK-B and BDNF in human neuroblastomas.
Nakagawara A; Azar CG; Scavarda NJ; Brodeur GM
Mol Cell Biol; 1994 Jan; 14(1):759-67. PubMed ID: 8264643
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
Eggert A; Ikegaki N; Liu XG; Brodeur GM
Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
[TBL] [Abstract][Full Text] [Related]
4. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells.
Eggert A; Ikegaki N; Liu X; Chou TT; Lee VM; Trojanowski JQ; Brodeur GM
Oncogene; 2000 Apr; 19(16):2043-51. PubMed ID: 10803465
[TBL] [Abstract][Full Text] [Related]
5. NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number.
Woo CW; Lucarelli E; Thiele CJ
Oncogene; 2004 Feb; 23(8):1522-30. PubMed ID: 14691455
[TBL] [Abstract][Full Text] [Related]
6. Distinct usages of phospholipase C gamma and Shc in intracellular signaling stimulated by neurotrophins.
Yamada M; Numakawa T; Koshimizu H; Tanabe K; Wada K; Koizumi S; Hatanaka H
Brain Res; 2002 Nov; 955(1-2):183-90. PubMed ID: 12419535
[TBL] [Abstract][Full Text] [Related]
7. Cultured hippocampal neurons show responses to BDNF, NT-3, and NT-4, but not NGF.
Ip NY; Li Y; Yancopoulos GD; Lindsay RM
J Neurosci; 1993 Aug; 13(8):3394-405. PubMed ID: 7688038
[TBL] [Abstract][Full Text] [Related]
8. Hierarchical analysis of the nerve growth factor-dependent and nerve growth factor-independent differentiation signaling pathways in PC12 cells with protein kinase inhibitors.
Campbell XZ; Neet KE
J Neurosci Res; 1995 Oct; 42(2):207-19. PubMed ID: 8568921
[TBL] [Abstract][Full Text] [Related]
9. Constitutive phosphorylation of TrkC receptors in cultured cerebellar granule neurons might be responsible for the inability of NT-3 to increase neuronal survival and to activate p21 Ras.
Zirrgiebel U; Lindholm D
Neurochem Res; 1996 Jul; 21(7):851-9. PubMed ID: 8873090
[TBL] [Abstract][Full Text] [Related]
10. Signaling pathways and survival effects of BDNF and NT-3 on cultured cerebellar granule cells.
Nonomura T; Kubo T; Oka T; Shimoke K; Yamada M; Enokido Y; Hatanaka H
Brain Res Dev Brain Res; 1996 Nov; 97(1):42-50. PubMed ID: 8946053
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tyrosine kinase domain properties for the neurotrophin receptors TrkA and TrkB.
Artim SC; Kiyatkin A; Lemmon MA
Biochem J; 2020 Oct; 477(20):4053-4070. PubMed ID: 33043964
[TBL] [Abstract][Full Text] [Related]
12. Effect of exogenous neurotrophins on Trk receptor phosphorylation, cell proliferation, and neurotrophin secretion by cells isolated from the human lamina cribrosa.
Lambert WS; Clark AF; Wordinger RJ
Mol Vis; 2004 Apr; 10():289-96. PubMed ID: 15105791
[TBL] [Abstract][Full Text] [Related]
13. Rapid stimulatory effects of brain-derived neurotrophic factor and neurotrophin-3 on somatostatin release and intracellular calcium rise in primary hypothalamic cell cultures.
Marmigère F; Choby C; Rage F; Richard S; Tapia-Arancibia L
Neuroendocrinology; 2001 Jul; 74(1):43-54. PubMed ID: 11435757
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 induces expression of peripherin and cooperates with Trk receptor signaling to promote neuronal differentiation in PC12 cells.
Sterneck E; Kaplan DR; Johnson PF
J Neurochem; 1996 Oct; 67(4):1365-74. PubMed ID: 8858917
[TBL] [Abstract][Full Text] [Related]
15. The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas.
Perez-Pinera P; Hernandez T; García-Suárez O; de Carlos F; Germana A; Del Valle M; Astudillo A; Vega JA
Mol Cell Biochem; 2007 Jan; 295(1-2):19-26. PubMed ID: 16862449
[TBL] [Abstract][Full Text] [Related]
16. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
Matsumoto K; Wada RK; Yamashiro JM; Kaplan DR; Thiele CJ
Cancer Res; 1995 Apr; 55(8):1798-806. PubMed ID: 7712490
[TBL] [Abstract][Full Text] [Related]
17. Fates of neurotrophins after retrograde axonal transport: phosphorylation of p75NTR is a sorting signal for delayed degradation.
Butowt R; von Bartheld CS
J Neurosci; 2009 Aug; 29(34):10715-29. PubMed ID: 19710323
[TBL] [Abstract][Full Text] [Related]
18. Neurotrophin effects on neuroblastoma cells: correlation with trk and p75NTR expression and influence of Trk receptor bodies.
Evangelopoulos ME; Weis J; Kruttgen A
J Neurooncol; 2004 Jan; 66(1-2):101-10. PubMed ID: 15015775
[TBL] [Abstract][Full Text] [Related]
19. Rational basis for Trk inhibition therapy for prostate cancer.
Weeraratna AT; Arnold JT; George DJ; DeMarzo A; Isaacs JT
Prostate; 2000 Oct; 45(2):140-8. PubMed ID: 11027413
[TBL] [Abstract][Full Text] [Related]
20. Activation of trk-A but not trk-B signal transduction pathway inhibits growth of neuroblastoma cells.
Lucarelli E; Kaplan D; Thiele CJ
Eur J Cancer; 1997 Oct; 33(12):2068-70. PubMed ID: 9516854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
